BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 37029757)

  • 1. Calcium/calmodulin-dependent protein kinase kinase 2 (CAMKK2) inhibitors: a novel approach in small molecule discovery.
    Devasahayam Arokia Balaya R; Chandrasekaran J; Kanekar S; Kumar Modi P; Dagamajalu S; Gopinathan K; Raju R; Prasad TSK
    J Biomol Struct Dyn; 2023; 41(24):15196-15206. PubMed ID: 37029757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CaMKK2 kinase domain interacts with the autoinhibitory region through the N-terminal lobe including the RP insert.
    Kylarova S; Psenakova K; Herman P; Obsilova V; Obsil T
    Biochim Biophys Acta Gen Subj; 2018 Oct; 1862(10):2304-2313. PubMed ID: 30053538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Depth Analysis of Kinase Cross Screening Data to Identify CAMKK2 Inhibitory Scaffolds.
    O'Byrne SN; Scott JW; Pilotte JR; Santiago ADS; Langendorf CG; Oakhill JS; Eduful BJ; Couñago RM; Wells CI; Zuercher WJ; Willson TM; Drewry DH
    Molecules; 2020 Jan; 25(2):. PubMed ID: 31941153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Research Resource: Roles for Calcium/Calmodulin-Dependent Protein Kinase Kinase 2 (CaMKK2) in Systems Metabolism.
    Marcelo KL; Ribar T; Means CR; Tsimelzon A; Stevens RD; Ilkayeva O; Bain JR; Hilsenbeck SG; Newgard CB; Means AR; York B
    Mol Endocrinol; 2016 May; 30(5):557-72. PubMed ID: 27003444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hinge Binder Scaffold Hopping Identifies Potent Calcium/Calmodulin-Dependent Protein Kinase Kinase 2 (CAMKK2) Inhibitor Chemotypes.
    Eduful BJ; O'Byrne SN; Temme L; Asquith CRM; Liang Y; Picado A; Pilotte JR; Hossain MA; Wells CI; Zuercher WJ; Catta-Preta CMC; Zonzini Ramos P; Santiago AS; Couñago RM; Langendorf CG; Nay K; Oakhill JS; Pulliam TL; Lin C; Awad D; Willson TM; Frigo DE; Scott JW; Drewry DH
    J Med Chem; 2021 Aug; 64(15):10849-10877. PubMed ID: 34264658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding and structural analyses of potent inhibitors of the human Ca
    Profeta GS; Dos Reis CV; Santiago ADS; Godoi PHC; Fala AM; Wells CI; Sartori R; Salmazo APT; Ramos PZ; Massirer KB; Elkins JM; Drewry DH; Gileadi O; Couñago RM
    Sci Rep; 2019 Nov; 9(1):16452. PubMed ID: 31712618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Broadening the scope of WEE1 inhibitors: identifying novel drug candidates via computational approaches and drug repurposing.
    Chandrasekaran J; Sivakumaresan Y; Shankar K; Dickson M; Laya Saravana Kumar S; Ramanathan L; Ahmad I; Patel H
    J Biomol Struct Dyn; 2023 Aug; ():1-11. PubMed ID: 37632319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1,2,6-Thiadiazinones as Novel Narrow Spectrum Calcium/Calmodulin-Dependent Protein Kinase Kinase 2 (CaMKK2) Inhibitors.
    Asquith CRM; Godoi PH; Couñago RM; Laitinen T; Scott JW; Langendorf CG; Oakhill JS; Drewry DH; Zuercher WJ; Koutentis PA; Willson TM; Kalogirou AS
    Molecules; 2018 May; 23(5):. PubMed ID: 29783765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein ligand interaction analysis against new CaMKK2 inhibitors by use of X-ray crystallography and the fragment molecular orbital (FMO) method.
    Takaya D; Niwa H; Mikuni J; Nakamura K; Handa N; Tanaka A; Yokoyama S; Honma T
    J Mol Graph Model; 2020 Sep; 99():107599. PubMed ID: 32348940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CaMKK2 is inactivated by cAMP-PKA signaling and 14-3-3 adaptor proteins.
    Langendorf CG; O'Brien MT; Ngoei KRW; McAloon LM; Dhagat U; Hoque A; Ling NXY; Dite TA; Galic S; Loh K; Parker MW; Oakhill JS; Kemp BE; Scott JW
    J Biol Chem; 2020 Nov; 295(48):16239-16250. PubMed ID: 32913128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional analysis of an R311C variant of Ca
    Xy Ling N; Langendorf CG; Hoque A; Galic S; Loh K; Kemp BE; Gundlach AL; Oakhill JS; Scott JW
    Bipolar Disord; 2020 Dec; 22(8):841-848. PubMed ID: 32216002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using the fluorescent properties of STO-609 as a tool to assist structure-function analyses of recombinant CaMKK2.
    Gerner L; Munack S; Temmerman K; Lawrence-Dörner AM; Besir H; Wilmanns M; Jensen JK; Thiede B; Mills IG; Morth JP
    Biochem Biophys Res Commun; 2016 Jul; 476(2):102-7. PubMed ID: 27178209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 14-3-3 protein directly interacts with the kinase domain of calcium/calmodulin-dependent protein kinase kinase (CaMKK2).
    Psenakova K; Petrvalska O; Kylarova S; Lentini Santo D; Kalabova D; Herman P; Obsilova V; Obsil T
    Biochim Biophys Acta Gen Subj; 2018 Jul; 1862(7):1612-1625. PubMed ID: 29649512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stabilization of Protein-Protein Interactions between CaMKK2 and 14-3-3 by Fusicoccins.
    Lentini Santo D; Petrvalska O; Obsilova V; Ottmann C; Obsil T
    ACS Chem Biol; 2020 Nov; 15(11):3060-3071. PubMed ID: 33146997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of CaMKK2 in Golgi-associated vesicle trafficking.
    Kennedy G; Gibson O; T O'Hare D; Mills IG; Evergren E
    Biochem Soc Trans; 2023 Feb; 51(1):331-342. PubMed ID: 36815702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 14-3-3 protein inhibits CaMKK1 by blocking the kinase active site with its last two C-terminal helices.
    Petrvalska O; Honzejkova K; Koupilova N; Herman P; Obsilova V; Obsil T
    Protein Sci; 2023 Nov; 32(11):e4805. PubMed ID: 37817008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Genetic Variation on Human CaMKK2 Regulation by Ca
    O'Brien MT; Oakhill JS; Ling NX; Langendorf CG; Hoque A; Dite TA; Means AR; Kemp BE; Scott JW
    Sci Rep; 2017 Feb; 7():43264. PubMed ID: 28230171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Akt activation by Ca
    Gocher AM; Azabdaftari G; Euscher LM; Dai S; Karacosta LG; Franke TF; Edelman AM
    J Biol Chem; 2017 Aug; 292(34):14188-14204. PubMed ID: 28634229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insightful t-SNE guided exploration spotlighting Palbociclib and Ribociclib analogues as novel WEE1 kinase inhibitory candidates.
    Muthuraj R; Gopal D; Ahmed I; Chandrasekaran J
    J Biomol Struct Dyn; 2024 Jan; ():1-13. PubMed ID: 38239070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Ca(2+)/Calmodulin/CaMKK2 Axis: Nature's Metabolic CaMshaft.
    Marcelo KL; Means AR; York B
    Trends Endocrinol Metab; 2016 Oct; 27(10):706-718. PubMed ID: 27449752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.